Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Suspended 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 33 Magnetic Resonance Spectroscopy 21 Biopsy 19 Cyclophosphamide 10 venetoclax 7 Nivolumab 6 Azacitidine 6 pembrolizumab 5 Vincristine 5 Etoposide 5 Bevacizumab 5 fludarabine phosphate 4 Surgical Procedures, Operative 4 Radiotherapy, Intensity-Modulated 4 Radiosurgery 4 Radiation 4 Injections 4 Doxorubicin 4 Cisplatin 4 fludarabine 3 durvalumab 3 decitabine and cedazuridine drug combination 3 X-Rays 3 Taxes 3 Tacrolimus 3 Surveys and Questionnaires 3 Prednisone 3 Leucovorin 3 Irinotecan 3 Ipilimumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × sotigalimab × 1 year × Clear all

NCT05419479 2026-06-04

Switch Maintenance in Pancreatic

Dana-Farber Cancer Institute

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡